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Summary
Objective: Whilst the characteristic pathologic feature of OA is the loss of hyaline cartilage, prior studies have demonstrated a poor
relationship between severity of reported knee pain and degree of radiographic change. The aim of this study was to examine the association
between knee symptoms and MRI cartilage volume.
Design: A cross-sectional study was performed to assess the association between knee symptoms and MRI cartilage volume in an
unselected, community based population. The subjects were 133 postmenopausal females. The subjects had a T2-weighted fat saturated
sagittal gradient-echo MRI performed of their right knee. Femoral, tibial and patella cartilage volumes were measured using three-
dimensional (3D) Slicer, a software that facilitates semi-automatic segmentation, generation of 3D surface models and quantitative analysis.
Qualitative data relating to symptoms, stiffness, pain, physical dysfunction and the quality of life using the WOMAC were recorded. The
statistical analyses conducted to determine measures of association between knee pain/symptoms and cartilage volume were correlation,
multiple regression and inter-quartile regression.
Results: Assessment of the association between patella cartilage volume and the WOMAC domains showed an inverse relationship between
patella cartilage volume and pain, function and global score in a model including body mass index, physical activity and leg extensor power
(all P0.01). Inter-quartile regression comparing the lowest 25% with highest 25% patella cartilage volume demonstrated a stronger inverse
relationship (P0.005).
Conclusion: This study suggests that alterations in patella volume are associated with pain, function and global scores of the WOMAC. In
participants with more knee pain, there was an association with severity of patella cartilage reduction. Other MRI cartilage volume features
were not strongly associated with WOMAC sub-scores.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction
The knee joint is a frequent site of pain in osteoarthritis
(OA)1, but the mechanisms that lead to knee pain in OA
remain unclear2. Traditionally, radiographic appearance
has been the cornerstone of diagnosis because the effects
of the pathological processes can be identified as features
on the X-ray: joint space narrowing, subchondral sclerosis
and osteophyte formation. However, less than 50% of
people with evidence of OA on plain radiographs have
symptoms related to these findings3,4, with substantive
evidence demonstrating a poor relationship between sever-
ity of reported knee pain and degree of radiographic
change5–7.
The syndrome of OA is a multifactorial process charac-
terized by changes in structure and function of the joint with
the central component being degradation and subse-
quent loss of articular cartilage8. Whilst the characteristic
pathologic feature of OA is the loss of hyaline cartilage this
tissue does not contain pain fibers. Pain fibers are present
in several other structures, however, that are often affected
by pathologic processes in knee OA, including the joint
capsule, ligaments in and around the knee joint, the outer
third of the meniscus, possibly the synovium, the bone in
the periosteum and the bone marrow9. However, cartilage
loss on arthroscopy appears to show substantial correlation
with pain and disability10. Because cartilage in OA holds
such a central position in the etiopathogenesis, pathologi-
cal investigations and drug development for OA it is critical
to understand whether it is clinically meaningful; that is,
whether it relates to pain and/or function.
In OA of the knee, cartilage is lost slowly. It can take
decades for cartilage to thin from its typical thickness of a
few millimeters to complete loss, and this rate of loss is
highly variable between individuals11. Techniques for
measuring joint space width (JSW) in the medial tibio-
femoral compartment, taken from carefully acquired radio-
graphs, have become accepted for quantifying changes in
articular cartilage thickness in the medial compartment of
OA knee12. JSW reliably measures cartilage thickness from
tibial plateau and distal portion of the femoral condyle in
one combined measurement, especially when image-
processing techniques are applied to digitized radio-
graphs13. Such techniques only examine one anatomical
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site, and cartilage loss occurs throughout the joint. Most
frequently, femoral cartilage lesions occur at, or posterior
to, the most distal point on the femoral condyles14, and the
more posteriorly sited lesions would be missed on a single
semi-flexed radiographic view. Moreover, it only provides
an indirect assessment of cartilage thickness.
Until recently, development in our understanding of OA
was limited by the lack of sufficiently sensitive endpoints
to detect early OA and small changes in progression.
Understanding of this disease and our ability to establish
efficacious treatment strategies have been confounded
by the inability to easily visualize the state of cartilage.
Magnetic resonance imaging (MRI) has many advantages
in providing such visualization, and recent efforts are yield-
ing a variety of approaches that offer the potential for
monitoring cartilage degradation non-destructively. MRI of
the knee has the advantage of covering the whole joint in
one examination. Various researchers have used cartilage
volume and thickness measured from MRI of the knee to
examine both normal and arthritic cartilage in patients15,16.
Recent research using MRI suggests an association
between bone marrow lesions and the presence of pain in
knee OA17.
The aim of this study was to examine the association
between knee symptoms and MRI cartilage volume in an
unselected, community based population.
Materials and methods
DESIGN
A cross-sectional single center study of postmenopausal
female twin pairs recruited from the general population via
a media campaign was carried out.
STUDY POPULATION
The subjects were 133 postmenopausal females (age
range 49–80 years) from the Australian National Health
and Medical Research Council (NHMRC) twin registry, a
volunteer sample recruited through a local media cam-
paign. Research was carried out in accordance with the
Declaration of Helsinki (1989) of the World Medical
Association and was approved by the hospital’s Human
Research Ethics Committee. Consent was obtained from
each subject after full explanation of the purpose, nature
and risk of all procedures used.
DATA ASCERTAINMENT
Demographic information was obtained by a standard-
ized investigator-administered questionnaire. The following
data were collected: personal details and lifestyle factors,
physical activity (Framingham Physical Activity Index8),
usual and past use of tobacco, menstrual cycle patterns
and use of oral contraceptives and reproductive history,
occupational history and past knee injury/trauma. In
addition, qualitative data relating to symptoms, stiffness,
pain, physical dysfunction and the quality of life using the
WOMAC19 were recorded. Lower limb strength was
measured on the Nottingham dynamic leg extensor power
rig20. Finally, clinical assessment was performed. This
included a medical history concentrating on joint, bone,
major organ disease, the use of medications, height, weight
and clinical examination of the knees, hips and hands. OA
was classified using the ACR Clinical Criteria21.
MAGNETIC RESONANCE IMAGING
Knees were imaged on a 1.5-T whole body magnetic
resonance unit (Signa Advantage GE Medical Systems
Milwaukee, WI) using a commercial transmit–receive
extremity coil. The following image sequence was per-
formed: three-dimensional (3D) spoiled gradient-echo
(SPGR) images; flip angle 40°; repetition time 30 ms;
echo time 7 ms; field of view 13 cm; bandwidth 16 kHz;
256256 matrix; slice thickness 1.2 mm; acquisition time
5 min 42 s; one acquisition. This method of acquisition
has been previously validated for cartilage volume
measurements22,23.
VOLUME MEASUREMENT
Cartilage volumes were measured using 3D Slicer, a
software that facilitates semi-automatic segmentation,
generation of 3D surface models and quantitative analy-
sis24. The measurement time to assess cartilage volume
for each subject was approximately 20 min. The process
incorporated automated intensity based segmentation, with
manual separation of femoral, tibial and patella cartilages
and correction of errors.
REPRODUCIBILITY
Reproducibility of this method was previously examined
on a sample of 10 subjects25. Three observers trained in
interpretation of musculoskeletal MRI held three standard-
ization sessions to minimize inconsistencies and indepen-
dently measured cartilage volumes on all of the subjects
blinded to patient details. One observer repeated these
measures a fortnight later. The intraclass correlation (ICC)
was computed from the analysis of variance on the vari-
ation in cartilage volume explainable by different observers.
The intra-observer ICCs were 0.99 (95% CI 0.98–1.00) for
tibial, patella and femoral cartilage volumes, whereas the
ICCs were 0.96 (95% CI 0.92–1.00) for femoral cartilage
volume and 0.97 (95% CI 0.94–1.00) for tibial and patella
cartilage volumes. The mean (range) cartilage volumes for
the 10 subjects were patella, 2.1 ml (1.0–3.4); tibia, 3.5 ml
(1.7–6.4) and femoral, 8.9 ml (5.4–14.2). The precision of
this method after subject re-positioning in the MRI machine
has not been assessed.
STATISTICAL ANALYSIS
The aim of the analysis was to examine the association
of knee pain/symptoms with cartilage volume.
Firstly, association was assessed by constructing a cor-
relation matrix of the variables of interest, namely the
various domains of the WOMAC and the cartilage volume
measures were obtained. Where an association was
detected, the influence of confounders was assessed by
adjusting for age, body mass index (BMI), physical activity,
leg extensor strength and relatedness using a generalized
estimating equation. The strength of association between
symptom score and cartilage volume was further assessed
in a stepwise regression model with backward elimination,
after adjustment using forced entry for the following inde-
pendent variables: age, BMI, physical activity and leg
extensor strength. Subsequent regression of the difference
in quantiles for significant variables was estimated from
the variance–covariance matrix of the estimators. Data
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analysis was performed and intraclass correlations were
estimated using STATA26.
Results
The basic characteristics of the subjects studied are
demonstrated in Table I. One hundred and thirty-three
postmenopausal females, mean age 60.1 years
(range=49–80 years), mean BMI 25.6 (SD=4.4), were
recruited. Subjects with knee pain (WOMAC pain
domain>0) were on average 3 years older, 1.8 cm taller,
5.3 kg heavier, had weaker leg extensor power of 4 W and
were more likely to have had a previous knee injury than
those without knee pain.
Qualitative data relating to the domains of the WOMAC
are presented in Table II. These represent those subjects
who had a pain score>0. This shows a wide range for all
three domains and the global score although the majority
would be considered mild.
The correlation between the WOMAC domains and the
cartilage volume measures is presented in Table III. There
was an inverse correlation between patella cartilage vol-
ume and WOMAC sub-scores for pain, function and global
score. GEE adjustment for relatedness did not alter the
results.
Further assessment of the association between patella
cartilage volume and the WOMAC domains is presented in
Table IV. This shows an inverse relationship between
patella cartilage volume and pain, function and global score
(all P0.01) with an R2 of 40% or greater with a model
including age, BMI, physical activity and leg extensor
power. BMI was the only other independently significant
predictor for the outcome measures of pain and function.
The strength of this association was stronger if the
delineation of the pain groups compared was set at higher
cut-points for pain (e.g., pain>2 (P0.008) and pain>5
(P0.008)).
Assessments of the inter-quartile regression are pre-
sented in Table V. Comparing the lowest 25% patella
cartilage volume with highest 25% cartilage volume
showed an inverse relationship (P0.005). This suggests
Table I
Characteristics of population studied (mean (SD))
Total (n=133) Knee pain (n=97)
(WOMAC pain domain>0)
No knee pain (n=36)
(WOMAC pain domain=0)
Age (years) 60.1 (7.7) 61.1 (7.4) 58.4 (8.9)
Height (cm) 159.9 (6.3) 160.1 (6.2) 158.3 (6.7)
Weight (kg) 65.5 (11.6) 66.4 (12.1) 61.1 (10.4)*
BMI (kg/m2) 25.6 (4.4) 25.9 (4.7) 24.3 (3.4)
Physical activity† 34.5 (5.9) 34.8 (6.1) 33.9 (5.3)
Previous knee injury (%) 34.4 38.1 19.4
Leg extensor power (W)‡ 62.6 (25.1) 61.3 (25.3) 65.3 (24.7)
Knee OA by ACR Clinical Criteria¶ 19 Right, 12 left, 9 bilateral 19 Right, 12 left, 9 bilateral
Femoral cartilage volume (ml) 10.0 (2.1) 10.2 (2.0) 9.4 (1.9)
Tibial cartilage volume (ml) 4.5 (1.2) 4.5 (1.3) 4.3 (0.9)
Patella cartilage volume (ml) 2.9 (0.8) 2.9 (0.8) 2.8 (0.7)
Total cartilage volume (ml) 17.3 (3.5) 17.6 (3.7) 16.5 (3.1)
*Significant difference between two groups (P0.02).
†Framingham Physical Activity Index18.
‡Nottingham University leg extension power rig20.
¶OA was classified using the ACR Clinical Criteria21.
Table II
WOMAC characteristics of pain population (mean (SD) of 97
postmenopausal females)
WOMAC domain
Pain ( /50) 5.5 (4.6) (Range=0.1–29.6) (Median=3.2)
Stiffness ( /20) 4.4 (4.5) (Range=0–18.1) (Median=3)
Function ( /170) 21.3 (23.3) (Range=1–109.7) (Median=12.6)
Global ( /240) 31.2 (31.8) (Range=1.9–154.1) (Median=17.1)
Table III
Correlation coefficients for relationship between WOMAC and MRI
findings
Pain Stiff-
ness
Function Global
Femoral cartilage volume 0.01 −0.08 −0.05 −0.04
Tibial cartilage volume −0.00 −0.07 −0.05 −0.05
Patella cartilage volume −0.21 −0.11 −0.23 −0.22
Total cartilage volume −0.04 −0.10 −0.10 −0.09
Table IV
Association between pain and patella volume in a stepwise mul-
tiple regression model (after adjustment using forced entry for the
following independent variables: age, BMI, physical activity and leg
extensor power)
R2 Measure Coefficient (95% CI) P value
Pain 0.40 BMI 0.3 (0.2 to 0.4) 0.000
Patella −1.2 (−2.1 to −0.2) 0.01
Function 0.42 BMI 1.2 (0.7 to 1.6) 0.000
Patella −4.8 (−8.5 to −1.0) 0.01
Global 0.45 BMI 1.7 (1.1 to 2.2) 0.000
Patella −6.5 (−11.6 to −1.4) 0.01
Table V
Difference in quartiles (25–75%) for WOMAC domains and patella
cartilage volume (unadjusted variables)
WOMAC domain Coefficient (95% CI) P value
Pain −2.2 (−3.7 to −0.7) 0.005
Function −8.4 (−15.2 to −1.6) 0.02
Global −11.9 (−16.5 to −7.3) 0.000
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that more extreme the populations compared, the stronger
the inverse relationship.
Discussion
This study suggests that alterations in patella volume are
associated with pain, function and global scores of the
WOMAC. In participants with less patella cartilage volume,
there was an association with severity of pain. Other MRI
cartilage volume features were not strongly associated with
WOMAC sub-scores.
Epidemiological research has previously relied upon a
global definition of OA incorporating X-ray features of both
osteophytes and joint space narrowing. Whilst this may be
more sensitive in radiographic surveys27, seeking links
between radiographic change and symptoms may be more
successful if individual features are incorporated17,28,29.
Previous research has demonstrated that bone marrow
edema, knee effusions, popliteal cysts and synovial thick-
ening are associated with pain in OA17,28. The results of
this study suggest another individual feature that should be
included in knee OA MRI assessment is patella cartilage
volume.
This supports previous research that has shown that
symptomatic knee OA may often be related to patello-
femoral disease that is not revealed by conventional
antero-posterior radiographs30,31. Our study confirms the
suggestion that joint space narrowing, previously detect-
able on skyline views, is a major cause of disability in OA
(independent of age, BMI, physical activity and leg exten-
sor power). This study also confirmed BMI as a predictor of
both pain and loss of function.
Data from the Framingham OA study4 and from the
Boston OA of the Knee study32 suggest that including
lateral radiographs (assessing patellofemoral disease) pro-
duces a greater concordance between clinical symptoms
and radiographic OA. McAlindon et al. showed that
patellofemoral joint OA was significantly associated with
disability (64 vs 25% in controls)31.
There are a number of limitations to these findings that
need to be considered. The results are cross-sectional and
any relationship between patella cartilage volume and pain
should be corroborated in a longitudinal study.
Cartilage contains no nociceptive nerve fibers, hence the
source of this pain is currently unexplained. One likely
possibility is that the reduction in cartilage alters the biome-
chanical load through the retropatellar surface, placing
greater deforming stress upon the underlying subchondral
bone.
The qualitative assessment of symptoms did not con-
sider the distribution of pain around the knee and further
assessment should elucidate whether this pain is more
anterior than either lateral or medial for example.
The number of subjects who had OA defined by ACR
Clinical Criteria is small (n22). It would be interesting to
repeat this research in a larger sample with a broader
representation of disease severity.
One limitation of conventional weight-bearing antero-
posterior knee radiograph, in which the joint is imaged in
extension, is that changes in knee pain may affect
extension, thereby altering the apparent thickness of the
articular cartilage33. Unlike plain radiography, MRI provides
a direct assessment of cartilage volume so this is unlikely to
affect the results.
In this population-based sample there is a suggestion
that knee symptoms relate more to patella volume than
other cartilage volumes. Further research on OA should
include an assessment of patella cartilage volume. This
finding has important implications for future epidemiologi-
cal research and clinical trials evaluating interventions
purported to have symptom modifying benefit through
structural modification.
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